Credit Suisse’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.49M | Sell |
43,721
-362
| -0.8% | -$28.9K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $3.51M | Sell |
44,083
-13,210
| -23% | -$1.05M | ﹤0.01% | 1536 |
|
|
2023
Q3 | $4M | Sell |
57,293
-3,280
| -5% | -$229K | ﹤0.01% | 1386 |
|
|
2023
Q2 | $4.35M | Buy |
60,573
+20,350
| +51% | +$1.46M | ﹤0.01% | 1418 |
|
|
2023
Q1 | $2.48M | Sell |
40,223
-4,919
| -11% | -$303K | ﹤0.01% | 1726 |
|
|
2022
Q4 | $3.48M | Sell |
45,142
-16,474
| -27% | -$1.27M | ﹤0.01% | 1532 |
|
|
2022
Q3 | $2.75M | Buy |
61,616
+25,413
| +70% | +$1.13M | ﹤0.01% | 1626 |
|
|
2022
Q2 | $1.39M | Sell |
36,203
-9,956
| -22% | -$381K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $1.91M | Sell |
46,159
-76,084
| -62% | -$3.15M | ﹤0.01% | 2100 |
|
|
2021
Q4 | $4.62M | Buy |
122,243
+23,661
| +24% | +$894K | ﹤0.01% | 1559 |
|
|
2021
Q3 | $3.25M | Buy |
98,582
+64,955
| +193% | +$2.14M | ﹤0.01% | 1813 |
|
|
2021
Q2 | $2.27M | Sell |
33,627
-5,206
| -13% | -$351K | ﹤0.01% | 2102 |
|
|
2021
Q1 | $2.2M | Buy |
38,833
+2,463
| +7% | +$139K | ﹤0.01% | 2078 |
|
|
2020
Q4 | $2.96M | Buy |
36,370
+13,918
| +62% | +$1.13M | ﹤0.01% | 1885 |
|
|
2020
Q3 | $1.6M | Sell |
22,452
-4,696
| -17% | -$335K | ﹤0.01% | 1964 |
|
|
2020
Q2 | $2.23M | Buy |
27,148
+11,368
| +72% | +$935K | ﹤0.01% | 1790 |
|
|
2020
Q1 | $928K | Sell |
15,780
-24,787
| -61% | -$1.46M | ﹤0.01% | 2161 |
|
|
2019
Q4 | $4.19M | Buy |
40,567
+22,245
| +121% | +$2.3M | ﹤0.01% | 1518 |
|
|
2019
Q3 | $371K | Sell |
18,322
-3,943
| -18% | -$79.8K | ﹤0.01% | 2951 |
|
|
2019
Q2 | $573K | Buy |
+22,265
| New | +$573K | ﹤0.01% | 2700 |
|
|
2017
Q3 | – | Sell |
-16,953
| Closed | -$93K | – | 3679 |
|
|
2017
Q2 | $93K | Buy |
+16,953
| New | +$93K | ﹤0.01% | 3337 |
|